Brothers Plead Guilty to Insider Trading of Sequenom Stock | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – A former Sequenom patent agent and his brother have pleaded guilty to insider trading, the US Attorney for the Southern District of California said.

According to a statement from US Attorney Laura Duffy, Aaron Scalia, a former patent agent at the San Diego-based molecular diagnostics firm, and his brother Stephen Scalia, have pleaded guilty to conspiring to trade stock options in Sequenom using insider information.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.

Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.

Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.

A new report indicates that women are underrepresented among US patent holders.